Verici Dx Publishes Circular for General Meeting on Fundraising
Why we think this is neutral
The RNS announcement is about the publication of a circular for a general meeting to approve a fundraising, which does not provide any specific financial or operational updates. As such, the news is neutral and does not warrant a strong positive or negative sentiment score.
Key Points
- Verici Dx has published a circular for a general meeting to approve a fundraising
- The fundraising is intended to accelerate commercial growth and support the scale-up of Tutivia revenues
- The company has recently secured Medicare coverage for Tutivia
Summary
Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, has announced the publication of a circular containing a notice of general meeting. The meeting is to seek shareholder approval to issue and allot new ordinary shares on a non-pre-emptive basis to enable the company to carry out a fundraising. The fundraising is required to extend the company's cash runway and support the scale-up of Tutivia revenues after securing Medicare coverage.